Overview
- 7 public-safe observations are available for this inspection.
- 7 structured CFR citations are represented.
- 4 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
Process filing
Cited by Selina M Mata, Yaw O Osei, Jamie M Bumpas, Casey L Hamblin
Raw materials, packaging, finished product
Cited by Selina M Mata, Yaw O Osei, Jamie M Bumpas, Casey L Hamblin
HACCP plan implementation
Cited by Selina M Mata, Yaw O Osei, Jamie M Bumpas, Casey L Hamblin
Critical limits
Cited by Selina M Mata, Yaw O Osei, Jamie M Bumpas, Casey L Hamblin
Monitoring - adequacy
Cited by Selina M Mata, Yaw O Osei, Jamie M Bumpas, Casey L Hamblin
Inspected site
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 108.25(c)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 114.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 123.11(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 123.6(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 123.6(c)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 123.6(c)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 123.9(f) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 7 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere